{"id":554934,"title":"Canada’s regulatory approach to drugs for rare diseases: orphan drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-23","captureTimestamp":"2026-02-23T17:18:26.380000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/licences-authorizations-registrations-drug-health-products/regulatory-approach-drugs-rare-diseases.html","snippet":"Canada’s regulatory approach to drugs for rare diseases: orphan drugs From Health Canada Canada's regulatory approach Clinical trials: apply and register Find a clinical trial Find drug reviews and decisions About orphan drugs and rare diseases Our role in bringing drugs to…","rawSnapshotUrl":"/api/snapshots/raw/554934","browseUrl":"https://replay.healtharchive.ca/job-6/20260223171826/https://www.canada.ca/en/health-canada/services/licences-authorizations-registrations-drug-health-products/regulatory-approach-drugs-rare-diseases.html#ha_snapshot=554934","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}